Company News

Gan & Lee Pharmaceuticals -- Joined exhibition in the 79th ADA

  • Time: 2019-07-05 14:48:46
  • Click Rate: 3851

The world’s largest, most prominent meeting on diabetes, the American Diabetes Association’s 79th Scientific Sessions, was successfully held in San Francisco, California. From June 7th to June 11th, the Scientific Sessions offered 180 forums. For 5 days, the Scientific Sessions offered researchers and health care professionals an amazing opportunity to share ideas and learn about the significant advances in diabetes research, treatment, and care. The American Diabetes Association has provided an unparalleled academic feast in forms of symposiums, small seminars, oral reports, poster exhibitions, specialist and expert panel discussions, and speeches. During the Scientific Sessions, over 2,000 original research presentations were released, and 10 highly-concerned research results were disclosed as well.

The American Diabetes Association also held offline exhibitions for diabetes industries. Only those US enterprises who have registered or listed diabetes treatment drugs, medical devices, or diabetes services, were invited to participate. Gan & Lee Pharmaceuticals was invited to attend as a leading enterprise in the diabetes insulin industry, and the only Chinese pharmaceutical enterprise who has been invited to participate.

 

During the exhibition, Gan & Lee hosted over three hundred experts and scholars.  Gan & Lee had in-depth communications with multi-dimensions such as brand products, marketing, and international teams with numerous specialists, while bringing positive marketing effects for future products to be launched in America.

 

 As a pharmaceutical enterprise with a sense of mission, Gan & Lee Pharmaceuticals has been listed in 12 countries on four continents. In the regulatory countries, such as Europe and the United States, products are currently in the clinical trial stage, which are expected to be approved for launch in the near future. Gan & Lee is constantly expanding its product lines to cover diabetes, blood diseases, tumors and many other fields of drugs. Gan & Lee provides high-quality medical products, with high scientific standards, and an entrepreneurial spirit, while benefiting patients worldwide.